Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

Enlivex management will host a webinar on July 30, 2026, to review its recently announced private placement and the status of its Rain protocol treasury strategy. The session will also cover clinical progress for Allocetra™, including the recent Regenerative Medicine Advanced Therapy (RMAT) designation granted by the FDA for treating knee osteoarthritis.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.